TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism

BACKGROUND: Transforming growth factor-β (TGFβ) is emerging as a promising target for cancer therapy, given its ability to promote progression of advanced tumors and to suppress anti-tumor immune responses. However, TGFβ also plays multiple roles in normal tissues, particularly during organogenesis,...

Full description

Saved in:
Bibliographic Details
Published in:J Immunother Cancer
Main Authors: Canè, Stefania, Van Snick, Jacques, Uyttenhove, Catherine, Pilotte, Luc, Van den Eynde, Benoit J
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2021
Subjects:
Basic Tumor Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919595/
https://ncbi.nlm.nih.gov/pubmed/33637600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001798
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items